SCHEMBL7754176

SCHEMBL7754176

C=C(C)C(=O)Nc1ccc(O)c(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.53
LMNA P02545 2/20 0.52
MAPT P10636 2/20 0.52
ALDH1A1 P00352 1/20 0.52
RXFP1 Q9HBX9 1/20 0.50
POLB P06746 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
RECQL P46063 1/20 0.48
BLM P54132 1/20 0.48
GAA P10253 1/20 0.46
EPHX2 P34913 2/20 0.46
HSD17B10 Q99714 1/20 0.45
EPHX1 P07099 1/20 0.44
BAZ1A Q9NRL2 1/20 0.44
NR1H4 Q96RI1 1/20 0.43
CYP3A4 P08684 1/20 0.42
APEX1 P27695 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL132197 0.86 GAA (0.62) TDP1LMNAMAPTRXFP1POLB
SCHEMBL29772937 0.86 GAA (0.62) TDP1LMNAMAPTRXFP1POLB
SCHEMBL30853148 0.84 TDP1 (0.57) TDP1ALDH1A1RXFP1POLBL3MBTL1
SCHEMBL21050613 0.84 TDP1 (0.57) TDP1ALDH1A1RXFP1POLBL3MBTL1
SCHEMBL5674663 0.82 HSD17B10 (0.59) LMNAMAPTALDH1A1POLBEPHX2
SCHEMBL31198183 0.82 HSD17B10 (0.59) LMNAMAPTALDH1A1POLBEPHX2
SCHEMBL22200937 0.81 TDP1 (0.54) TDP1LMNAMAPTALDH1A1RXFP1
SCHEMBL15782653 0.81 TDP1 (0.54) TDP1MAPTALDH1A1RXFP1POLB
SCHEMBL10864160 0.81 POLB (0.55) TDP1LMNAMAPTALDH1A1RXFP1
SCHEMBL13921948 0.81 DHODH (0.51) TDP1LMNAMAPTALDH1A1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0704539-B1 Chemiluminescent reagent and assay using a substituted acetanilide for light generation JOHNSON & JOHNSON CLIN DIAG (US) 2001-02-28 EP disclosed
EP-0603954-B1 Immunoassay using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer JOHNSON & JOHNSON CLIN DIAG (US) 2000-03-08 EP disclosed
EP-0603953-B1 Use of 4' of 5'-hydroxy and 4'- or 5'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods JOHNSON & JOHNSON CLIN DIAG (US) 1999-02-17 EP disclosed
US-5736335-A Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase-labeled reagents EASTMAN KODAK COMPANY (US) 1998-04-07 US disclosed
US-5705357-A DETECTING PEROXIDASE; SENSITIVITY, LOW BACKGROUND; MEDICAL DIAGNOSIS JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) 1998-01-06 US disclosed
US-5641635-A Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase-labeled reagents EASTMAN KODAK COMPANY (US) 1997-06-24 US disclosed
EP-0704539-A2 Chemiluminescent reagent and assay using a substituted acetanilide for light generation JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) 1996-04-03 EP disclosed
US-5372931-A Use of 4'-hydroxy- and 4'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods EASTMAN KODAK COMPANY (US) 1994-12-13 US disclosed
US-5372932-A Peroxidase-labeled immunoreactant; stabiliztion with a 4-hydroxy or 4-alkoxyarylacetamide EASTMAN KODAK COMPANY (US) 1994-12-13 US disclosed
EP-0603953-A1 Use of 4' of 5'-hydroxy and 4'- or 5'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods Johnson & Johnson Clinical Diagnostics, Inc. (US) 1994-06-29 EP disclosed
EP-0603954-A2 Analytical element and immunoassay using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer Johnson & Johnson Clinical Diagnostics, Inc. (US) 1994-06-29 EP disclosed